LAMEDITECH Co., Ltd.
Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system; and … Read more
LAMEDITECH Co., Ltd. (462510) - Net Assets
Latest net assets as of September 2025: ₩11.27 Billion KRW
Based on the latest financial reports, LAMEDITECH Co., Ltd. (462510) has net assets worth ₩11.27 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩19.55 Billion) and total liabilities (₩8.28 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩11.27 Billion |
| % of Total Assets | 57.64% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
LAMEDITECH Co., Ltd. - Net Assets Trend (2022–2024)
This chart illustrates how LAMEDITECH Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LAMEDITECH Co., Ltd. (2022–2024)
The table below shows the annual net assets of LAMEDITECH Co., Ltd. from 2022 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩19.15 Billion | +123.99% |
| 2023-12-31 | ₩8.55 Billion | +172.76% |
| 2022-12-31 | ₩-11.75 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to LAMEDITECH Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1827633313000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩4.33 Billion | 22.58% |
| Other Components | ₩50.47 Billion | 263.52% |
| Total Equity | ₩19.15 Billion | 100.00% |
LAMEDITECH Co., Ltd. Competitors by Market Cap
The table below lists competitors of LAMEDITECH Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Digital Multimedia Technology Co.Ltd
KQ:134580
|
$15.69 Million |
|
International Isotopes Inc
OTCQB:INIS
|
$15.69 Million |
|
01 Communique Laboratory Inc
OTCQB:OONEF
|
$15.69 Million |
|
FRANCHETTI S.P.A.
F:D0E
|
$15.69 Million |
|
Logindo Samudramakmur Tbk
JK:LEAD
|
$15.68 Million |
|
Aimflex Bhd
KLSE:0209
|
$15.68 Million |
|
TH International Limited
NASDAQ:THCH
|
$15.68 Million |
|
Ordell Minerals Ltd
AU:ORD
|
$15.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LAMEDITECH Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,551,311,890 to 19,154,104,270, a change of 10,602,792,380 (124.0%).
- Net loss of 9,483,788,330 reduced equity.
- Share repurchases of 20,314,325,500 reduced equity.
- New share issuances of 20,314,325,500 increased equity.
- Other factors increased equity by 20,086,580,710.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-9.48 Billion | -49.51% |
| Share Repurchases | ₩20.31 Billion | -106.06% |
| Share Issuances | ₩20.31 Billion | +106.06% |
| Other Changes | ₩20.09 Billion | +104.87% |
| Total Change | ₩- | 123.99% |
Book Value vs Market Value Analysis
This analysis compares LAMEDITECH Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.20x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | ₩-1358.61 | ₩4865.00 | x |
| 2023-12-31 | ₩988.51 | ₩4865.00 | x |
| 2024-12-31 | ₩2214.16 | ₩4865.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LAMEDITECH Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -49.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -144.20%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.17x
- Recent ROE (-49.51%) is below the historical average (-48.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 0.00% | -215.50% | 0.26x | 0.00x | ₩-3.25 Billion |
| 2023 | -97.12% | -284.58% | 0.26x | 1.32x | ₩-9.16 Billion |
| 2024 | -49.51% | -144.20% | 0.29x | 1.17x | ₩-11.40 Billion |
Industry Comparison
This section compares LAMEDITECH Co., Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $98,321,642,752
- Average return on equity (ROE) among peers: 7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LAMEDITECH Co., Ltd. (462510) | ₩11.27 Billion | 0.00% | 0.73x | $15.69 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |